Table 1.
Demographic data
| Variablea | n = 127 |
|---|---|
| Age (years) | 64.5 (13.1) |
| BMI | 24.0 (6.0) |
| Male Sex | 62 (48.8%) |
| CCI | 7.4 (2.4) |
| ASA | |
| IV | 61 (48.0%) |
| III | 59 (46.5%) |
| Unknown | 7 (5.5%) |
| Excessive Alcohol Consumption b | 7 (5.5%) |
| Smoking | |
| Never Smoked | 28 (22.1%) |
| Ex-smoker | 74 (58.3%) |
| Smoker | 25 (19.7%) |
| Reported Degree of Dyspnoea | |
| None | 16 (12.6%) |
| Mild-moderate | 59 (46.5%) |
| Severe | 52 (40.9%) |
| Respiratory Status | |
| Respiratory Support | 40 (31.5%) |
| Intubated | 8 (6.3%) |
| Urgency of Index Intervention | |
| Elective | 42 (33.1%) |
| Semi-urgent | 57 (44.9%) |
| Urgent | 28 (22.1%) |
| Level of Stenosis | |
| Trachea | 19 (15.0%) |
| Tracheobronchial | 26 (20.5%) |
| Unilateral bronchi | 69 (54.3%) |
| Bilateral bronchi | 13 (10.2%) |
| Freitag Classification | |
| Intraluminal | 108 (85.0%) |
| Extern Compression | 19 (15.0%) |
| Index Intervention | |
| Stent Insertion | 76 (59.8%) |
| Debulking & Dilation | 51 (40.2%) |
| Malignancy | |
| Lung | 95 (74.8%) |
| NSCLC | 80 (63.0%) |
| SCLC | 5 (3.9%) |
| Other Primary Lung Cancer | 10 (7.9%) |
| Oesophagus | 9 (7.1%) |
| Thyroid | 3 (2.4%) |
| Metastases | 18 (14.2%) |
| Unclassified | 2 (1.6%) |
| Postoperative Oncologic Therapy | |
| Chemoradiotherapy | 62 (48.8%) |
| Immunotherapyc | 8 (6.3%) |
| None | 57 (44.9%) |
aContinuous data are presented as mean (SD) and categorical data as numbers (percentage)
bRecommendations: less than 10 standard drinks per week
cImmunotherapy was introduced in Denmark in 2017